The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several risk and prognostic factors in major chronic diseases.
Inhabitant of the city of Hamburg at the time of inclusion into the study (Inclusion is time of written consent)
Age 45 to 74 years
Personally signed informed consent
Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation
Physical or psychological incapability to travel to the study center and to cooperate in the investigations
Population based cohort, participants are identified by a random sample from the official inhabitant data file divided into gender and six age strata.
Cohort
Prospective
Not listed
self-reported Information on changes in health in the participants
coronary artery disease atrial fibrillation heart failure dementia stroke cancer such as prostate cancer and skin cancer chronic kidney diseases migraine musculoskeletal diseases such as osteoporosis and bone metastasis ocular diseases such as glaucoma, macular degeneration, fundus hypertonicus, retinal vessel disease and neoplasm oral health including periodontal disease, oropharyngeal cancer and human papillomavirus (HPV)-infection psychiatric and psychosomatic disorders such as mental disorder or late - last depression pulmonary diseases such as obstructive lung disease sexual disorder skin diseases such as psoriasis, chronic wounds and inflammation vascular diseases such as aortic aneurysm, thrombosis and peripheral arterial disease
Click on the lead sponsor to view all of their trials.
Universitätsklinikum Hamburg-Eppendorf
Lead sponsor
University of Hamburg-Eppendorf
Collaborator
Martini-Klinik am UKE GmbH
Collaborator
